Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hasse

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
The Lancet. Microbe|November 4, 2024
Endocarditis associated with contamination of cardiovascular bioprostheses with Mycobacterium chelonae: a collaborative microbiological studyJudith Kikhney, Inna Friesen, Solveigh Wiesener, et al.
European Heart Journal|July 19, 2015
Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgeryPhilipp Kohler, Stefan P Kuster, Guido Bloemberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2023
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke CriteriaVance G Fowler, David T Durack, Christine Selton-Suty, et al.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
Nature Communications|January 14, 2026
Loss of Fsr quorum sensing promotes biofilm formation and worsens outcomes in enterococcal infective endocarditisHaris Antypas, Verena Schmidtchen, Willy Isao Staiger, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
International Journal of Cancer|June 20, 2019
Cervical cancer risk in women living with HIV across four continents: A multicohort studyEliane Rohner, Lukas Bütikofer, Kurt Schmidlin, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
The Lancet. Microbe|November 4, 2024
Endocarditis associated with contamination of cardiovascular bioprostheses with Mycobacterium chelonae: a collaborative microbiological studyJudith Kikhney, Inna Friesen, Solveigh Wiesener, et al.
European Heart Journal|July 19, 2015
Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgeryPhilipp Kohler, Stefan P Kuster, Guido Bloemberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2023
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke CriteriaVance G Fowler, David T Durack, Christine Selton-Suty, et al.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
Nature Communications|January 14, 2026
Loss of Fsr quorum sensing promotes biofilm formation and worsens outcomes in enterococcal infective endocarditisHaris Antypas, Verena Schmidtchen, Willy Isao Staiger, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
International Journal of Cancer|June 20, 2019
Cervical cancer risk in women living with HIV across four continents: A multicohort studyEliane Rohner, Lukas Bütikofer, Kurt Schmidlin, et al.
Pageof 14